Description:
Home Page: www.vrtx.com
50 Northern Avenue
Boston,
MA
02210
United States
Phone:
617 341 6100
Officers
| Name | Title |
|---|---|
| Dr. Jeffrey Marc Leiden M.D., Ph.D. | Exec. Chairman |
| Dr. Reshma Kewalramani FASN, M.D. | CEO, Pres & Director |
| Mr. Charles F. Wagner Jr. | Exec. VP & CFO |
| Mr. Stuart A. Arbuckle B.Sc. | Exec. VP & COO |
| Dr. Ourania Tatsis Ph.D. | Exec. VP and Chief Regulatory & Quality Officer |
| Ms. Kristen C. Ambrose | Chief Accounting Officer & SVP of Accounting, Tax, Treasury, Strategic Sourcing & Corp. Services |
| Dr. David M. Altshuler M.D., Ph.D. | Exec. VP of Global Research & Chief Scientific Officer |
| Mr. Mike Tirozzi | SVP and Chief Information & Data Officer |
| Susie Lisa | Sr. VP of Investor Relations |
| Mr. Damian W. Wilmot Esq. | Sr. VP, Chief Risk and Compliance Officer |
Exchange: SA
Country: BR
Currency: Brazilian real (R$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 26.5957 |
|---|---|
| Trailing PE: | 32.266 |
| Price-to-Book MRQ: | 6.7125 |
| Price-to-Sales TTM: | 56.3676 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 4800 |